tiprankstipranks
Advertisement
Advertisement

SUPN Stock Latest News

Supernus Acquires NV-5138 Asset in New Agreement
Company AnnouncementsSupernus Acquires NV-5138 Asset in New Agreement
24d ago
8K
SUPN
Supernus enters into asset purchase agreement with Navitor
PremiumThe Fly
Supernus enters into asset purchase agreement with Navitor
24d ago
SUPN
Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
PremiumCompany Announcements
Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
2M ago
SUPN
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
PremiumCompany Announcements
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
2M ago
SUPN
Supernus price target raised to $65 from $60 at TD Cowen
PremiumThe Fly
Supernus price target raised to $65 from $60 at TD Cowen
2M ago
SUPN
Buy Rating Backed by Reaccelerating Onapgo Demand, Sage Integration Upside, and Attractive CNS-Driven Valuation
PremiumRatingsBuy Rating Backed by Reaccelerating Onapgo Demand, Sage Integration Upside, and Attractive CNS-Driven Valuation
2M ago
SUPN
Closing Bell Movers: First Solar down 12% on earnings miss
Premium
The Fly
Closing Bell Movers: First Solar down 12% on earnings miss
2M ago
CCC
CWH
Supernus boosts executive pay with new equity incentives
Premium
Company Announcements
Supernus boosts executive pay with new equity incentives
2M ago
8K
SUPN
Supernus reports Q4 EPS (7c) vs 27c last year
PremiumThe Fly
Supernus reports Q4 EPS (7c) vs 27c last year
2M ago
SUPN
Supernus sees FY26 revenue $840M-$870M, consensus $861.24M
PremiumThe Fly
Supernus sees FY26 revenue $840M-$870M, consensus $861.24M
2M ago
SUPN
Is SUPN a Buy, Before Earnings?
PremiumPre-Earnings
Is SUPN a Buy, Before Earnings?
2M ago
SUPN
Supernus: Zurzuvae Outperformance and High‑Margin Collaboration Revenue Underpin Buy Rating and $65 Price Target
PremiumRatings
Supernus: Zurzuvae Outperformance and High‑Margin Collaboration Revenue Underpin Buy Rating and $65 Price Target
3M ago
SUPN
Supernus Revises Merger Milestone Payment Obligations Agreement
PremiumCompany AnnouncementsSupernus Revises Merger Milestone Payment Obligations Agreement
3M ago
8K
SUPN
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
Premium
The Fly
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
4M ago
ATAI
CYBN
Supernus price target raised to $55 from $50 at Stifel
Premium
The Fly
Supernus price target raised to $55 from $50 at Stifel
4M ago
SUPN
Supernus Pharmaceuticals: Strategic Growth, Clinical Advances, and Strong Financial Synergies Drive Buy Rating
PremiumRatings
Supernus Pharmaceuticals: Strategic Growth, Clinical Advances, and Strong Financial Synergies Drive Buy Rating
4M ago
SUPN
Supernus management to meet virtually with Cantor Fitzgerald
PremiumThe Fly
Supernus management to meet virtually with Cantor Fitzgerald
5M ago
SUPN
Bank of America Highlights Five Stocks It Says Still Offer Clear Upside in 2025
PremiumMarket News
Bank of America Highlights Five Stocks It Says Still Offer Clear Upside in 2025
5M ago
CR
BAC
Supernus Pharmaceuticals’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Supernus Pharmaceuticals’ Earnings Call: Growth Amid Challenges
6M ago
SUPN
Supernus Pharmaceuticals Reports Strong Q3 2025 Growth
PremiumCompany AnnouncementsSupernus Pharmaceuticals Reports Strong Q3 2025 Growth
6M ago
SUPN
Supernus Pharmaceuticals: Strong Product Performance and Strategic Management Drive Buy Rating
Premium
Ratings
Supernus Pharmaceuticals: Strong Product Performance and Strategic Management Drive Buy Rating
6M ago
SUPN
Supernus reports Q3 EPS (80c) vs. 69c last year
Premium
The Fly
Supernus reports Q3 EPS (80c) vs. 69c last year
6M ago
SUPN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >